Inventor · disambiguated record
Jon Amund Eriksen
Also filed as: ERIKSEN JON · ERIKSEN JON AMUND
18 granted patents·8 pending applications·369 citations·filing 1990–2022
95Inventor score
Top patents by PatentIndex Score
26 records- 0194US7794723B2Antigenic peptides derived from telomeraseGEMVAX AS·Filed 2006·Granted Sep 14, 2010·47 cites·8 claims
- 0291US10596239B2Peptide mixtureTARGOVAX ASA·Filed 2017·Granted Mar 24, 2020·8 cites·5 claims
- 0391US10456457B2Peptide mixtureTARGOVAX ASA·Filed 2017·Granted Oct 29, 2019·8 cites·6 claims
- 0491US10335473B2Peptide mixtureTARGOVAX ASA·Filed 2017·Granted Jul 2, 2019·8 cites·8 claims
- 0590US6759046B1PeptidesGEMVAX AS·Filed 1999·Granted Jul 6, 2004·74 cites·9 claims
- 0689US8614177B2PeptidesGAUDERNACK GUSTAV·Filed 2011·Granted Dec 24, 2013·7 cites·9 claims
- 0789US8193326B2Nucleic acids encoding novel TERT polypeptidesGAUDERNACK GUSTAV·Filed 2008·Granted Jun 5, 2012·7 cites·2 claims
- 0889US7863244B2PeptidesGEMVAX AS·Filed 2006·Granted Jan 4, 2011·9 cites·15 claims
- 0988US7192927B2PeptidesGEMVAX AS·Filed 2004·Granted Mar 20, 2007·20 cites·12 claims
- 1085US7375117B2PolypeptidesGEMVAX AS·Filed 2006·Granted May 20, 2008·7 cites·13 claims
- 1185US7078416B2PolypeptidesGEMVAX AS·Filed 2001·Granted Jul 18, 2006·21 cites·30 claims
- 1284US5961978ATherapeutically useful peptides and peptide fragmentsNORSK HYDRO AS·Filed 1995·Granted Oct 5, 1999·62 cites·138 claims
- 1383US9775892B2Peptide mixtureTARGOVAX ASA·Filed 2014·Granted Oct 3, 2017·4 cites·4 claims
- 1483US9757439B2Peptide vaccine comprising mutant RAS peptide and chemotherapeutic agentTARGOVAX ASA·Filed 2015·Granted Sep 12, 2017·5 cites·18 claims
- 1576US6861057B2Immunogenic β-amyloid peptideGEMVAX AS·Filed 1999·Granted Mar 1, 2005·36 cites·2 claims
- 1675US10267458B2Hydrogen storage and release arrangementHystorsys AS·Filed 2017·Granted Apr 23, 2019·4 cites·12 claims
- 1773US7030211B1Antigenic peptides derived from telomeraseGEMVAX AS·Filed 1990·Granted Apr 18, 2006·42 cites·9 claims
- 1868US9241968B2Nonapeptide with anti-tumour activityHAUG BENGT ERIK·Filed 2009·Granted Jan 26, 2016·0 cites·13 claims
- 1961US2012269858A1PolypeptidesGAUDERNACK GUSTAV·Filed 2012·Application pending·0 cites
- 2053US2023203130A1A peptide cocktailHUBRO THERAPEUTICS AS·Filed 2021·Application pending·0 cites
- 2152US2022213170A1PeptidesHUBRO THERAPEUTICS AS·Filed 2020·Application pending·0 cites
- 2249US2024287149A1Mutated gnas peptidesOSLO UNIV HOSPITAL·Filed 2022·Application pending·0 cites
- 2349US2016176923A1Nonapeptide with anti-tumour activityLYTIX BIOPHARMA AS·Filed 2015·Application pending·0 cites
- 2449US2022154218A1Oncolytic adenoviral vector expressing peptidylarginine deiminase and tissue inhibitor of metalloproteinaseTARGOVAX ASA·Filed 2020·Application pending·0 cites
- 2549US2022152134A1Oncolytic adenoviral vector expressing a member of the b7 family of costimulatory ligands and adaTARGOVAX ASA·Filed 2020·Application pending·0 cites
- 2637US2019374628A1Mutated fragments of the ras proteinTARGOVAX ASA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jon Amund Eriksen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →